1.Alprostadil the pneumoconiosis rheology and respiratory function of patients with pulmonary heart disease clinical research.
Chui-yun LUI ; Xiang-wen GONG ; Qian CHEN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2012;30(9):694-696
Adult
;
Aged
;
Alprostadil
;
therapeutic use
;
Female
;
Hemorheology
;
Humans
;
Male
;
Middle Aged
;
Pneumoconiosis
;
blood
;
drug therapy
;
physiopathology
;
Respiratory Function Tests
2.Clinical analysis of peripheral blood stem cell mobilization regimens in autologous transplantation for treating non-Hodgkin's lymphoma.
Si-Yong HUANG ; Li LIU ; Miao-Wang HAO ; Dan-Dan YIN ; Yan-Lan WU ; Ren-An CHEN ; Gou-Hui LI ; Qian LUI ; Jing-Cheng WANG ; Hua HE ; Ying-Min LIANG
Journal of Experimental Hematology 2011;19(6):1415-1418
The purpose of this study was to compare the efficacy of CEP plus G-CSF and CVP plus G-CSF regimens in the mobilization and collection of peripheral blood hematopoietic stem cells (PBHSC), and in the hematopoietic recovery. 57 patients with non-Hodgkin's lymphoma (NHL) underwent autologous PBHSC transplantation were analyzed retrospectively. The PBHSC were mobilized and collected by using CEP plus G-CSF and CVP plus G-CSF respectively, and were retransfused into these NHL patients after preconditioning, then the mobilization efficacy, adverse reactions and hematopoietic recovery were analyzed. The results showed that the WBC count decreased to ≤ 1.0 × 10(9)/L, platelet amount dropped to ≤ 40 × 10(9)/L during peripheral blood stem cell mobilization of all patients, which indicated successful collection of PBHSC. The mean value of (4.38 ± 3.40) × 10(8)/kg mononuclear cells (MNC) containing (2.79 ± 2.53) × 10(6)/kg CD34(+) cells were collected in CEP plus G-CSF group, while the mean value of (3.31 ± 1.23) × 10(8)/kg MNC containing (2.02 ± 0.87) × 10(6)/kg CD34(+) cells were collected in CVP plus G-CSF group. The efficacy of mobilization in CEP plus G-CSF group was significantly higher than that in CVP plus G-CSF group (p < 0.05). After preconditioning, bone marrow was suppressed in all patients. The average time of WBC count recovery to ≥ 1.0 × 10(9)/L was 11.4 days in CEP plus G-CSF group and 12.3 days in CVP plus G-CSF group; the average time of platelet amount recovery to ≥ 50 × 10(9)/L was 18.6 days in CEP plus G-CSF group and 19.3 days in CVP plus G-CSF group. The statistical analysis showed no significant difference in the average time of hematopoietic recovery between 2 groups. It is concluded that autologous PBHSC transplantation shows significant effect for treatment of patients with NHL. Either modified CEP or CVP plus G-CSF regimen is safe and effective in PBHSC mobilization. The CEP plus G-CSF regimen is better than CVP plus G-CSF regimen.
Adolescent
;
Adult
;
Child
;
Female
;
Hematopoietic Stem Cell Mobilization
;
methods
;
Humans
;
Lymphoma, Non-Hodgkin
;
therapy
;
Male
;
Middle Aged
;
Peripheral Blood Stem Cell Transplantation
;
Retrospective Studies
;
Transplantation, Autologous
;
Young Adult